Zepp Health Corporation (ZEPP) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear

Zepp Health Corporation

NYSE: ZEPP · Real-Time Price · USD
49.48
-0.15 (-0.30%)
At close: Oct 03, 2025, 3:59 PM
49.54
0.12%
Pre-market: Oct 06, 2025, 06:01 AM EDT

Zepp Health Income Statement

Financials in CNY. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
1.44B 1.31B 1.31B 1.47B 1.78B 2.16B 2.52B 2.96B 3.61B 4.06B 4.17B 4.79B 5.14B 5.85B 6.26B 6.54B 7.14B 6.43B
Cost of Revenue
898.49M 802.36M 809.38M 922.24M 1.15B 1.49B 1.85B 2.29B 2.9B 3.3B 3.36B 3.88B 4.14B 4.65B 4.95B 5.19B 5.65B 5.1B
Gross Profit
539.17M 503.56M 505.54M 551.72M 636.51M 664.69M 661.73M 669.67M 704.38M 758.29M 807.29M 912.95M 995.49M 1.2B 1.31B 1.36B 1.49B 1.33B
Operating Income
-330.2M -358.03M -339.61M -270.14M -171.32M -174.31M -210.89M -283.67M -370.94M -408.33M -412.24M -333.9M -195.25M -11.5M 93.17M 145.88M 162.7M 100.39M
Interest Income
18.54M 23.31M 26.41M 26.69M 26.88M 26.13M 23.2M 22.1M 18.71M 14.75M 12.91M 10.98M 11.14M 27.01M 30.27M 41.65M 48.23M 43.78M
Pretax Income
-459.08M -483.66M -447.57M -267.14M -170.91M -176.76M -232.68M -318.8M -375.04M -412.5M -355.76M -243.92M -135.81M 90.02M 146.9M 241.71M 275.86M 188.36M
Net Income
-560.46M -583.57M -546.97M -287.55M -191.65M -185.06M -215.65M -279.26M -300.07M -336.27M -287.69M -178.79M -111.76M 89.29M 137.11M 214.39M 244.79M 165.36M
Selling & General & Admin
542.7M 536.52M 512.93M 490.75M 477.62M 495.26M 507.5M 557.47M 621.94M 674.66M 699.5M 743.55M 711.78M 700.8M 697.54M 660.27M 710.95M 665.81M
Research & Development
326.67M 325.07M 332.21M 331.11M 330.22M 343.73M 365.13M 395.87M 453.38M 491.96M 520.02M 503.31M 478.95M 508.76M 516.59M 550.8M 612.21M 568.4M
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
869.37M 861.59M 845.15M 821.86M 807.84M 838.99M 872.63M 953.35M 1.08B 1.17B 1.22B 1.25B 1.19B 1.21B 1.21B 1.21B 1.32B 1.23B
Interest Expense
38.37M 39.4M 39.97M 39.7M 42.44M 45.17M 48.11M 53.37M 57.33M 58.93M 57.23M 56.06M 53.78M 49.83M 44.89M 30.55M 17.09M 6.73M
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
1.77B 1.66B 1.65B 1.74B 1.95B 2.33B 2.73B 3.24B 3.98B 4.47B 4.58B 5.13B 5.33B 5.86B 6.16B 6.4B 6.97B 6.33B
Income Tax Expense
101.26M 99.86M 99.58M 20.66M 21.13M 8.81M -16.56M -38.76M -74.26M -75.47M -67.38M -64.46M -23.23M 1.58M 10.64M 28.06M 30.13M 20.98M
Shares Outstanding (Basic)
3.96M 3.86M 4.04M 4.04M 4.05M 4.06M 3.77M 4M 3.77M 3.81M 3.81M 3.81M 3.8M 3.9M 3.96M 3.95M 3.93M 3.92M
Shares Outstanding (Diluted)
3.96M 4.01M 4.04M 4.04M 4.05M 4.06M 3.77M 4M 3.81M 3.83M 3.83M 3.83M 3.84M 3.9M 4.13M 4.16M 4.12M 3.92M
EPS (Basic)
-141.28 -146.64 -135.4 -70.84 -47.72 -46.72 -56.36 -73.72 -78.28 -87.76 -74.84 -45.92 -28.92 22.44 34.88 55.24 63.56 43.48
EPS (Diluted)
-139.76 -145.12 -113.2 -46.52 -23.4 -22.6 -54.6 -74.16 -78.72 -88.32 -75.52 -46.72 -30.08 20.48 33.20 52.32 60.00 40.80
EBITDA
-381.24M -411.1M -373M -231.11M -135.04M -134.41M -188.48M -255.24M -311.44M -365.09M -316.51M -221.2M -112.8M 95.8M 150.79M 245.22M 264.48M 199.07M
EBIT
-390.47M -415.22M -377.12M -235.15M -139.08M -138.45M -192.52M -255.24M -311.44M -365.09M -316.51M -221.2M -112.8M 95.8M 150.79M 245.22M 264.48M 199.07M
Depreciation & Amortization
9.24M 4.12M 4.12M 4.04M 4.04M 4.04M 4.04M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a